Ultime notizie per Cogstate (OTC:COGZF) Azioni

Cogstate Ltd is a cognitive science company. The principal activity of the group is Creation, validation and commercialisation of digital brain health assessments; and Design and provision of quality assurance services in clinical trials, focused on the administration, scoring and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.

Cogstate Ltd

CogState (COGZF) today announced that it will acquire the remaining 50% stake in Axon Sports, resulting in Axon Sports becoming a 100% owned subsidiary.

Axon Sports provides online cognitive assessment to assist in evaluating and managing sports-related concussions. For CogState, the management of concussion in sport is a fast growing market, providing enormous opportunity for growth of revenue and profitability in the short term.

The 100% control of Axon Sports will allow CogState to utilise the Axon Sports online testing and associated materials to pursue the sports concussion markets outside North America.

Importantly, 100% control of Axon Sports means that CogState is in a position to take full advantage of current opportunities being discussed with large pharmaceutical companies with the aim of making CogState technology available to clinicians as a low cost, non -invasive, screening tool that could be provided within a clinician‟s surgery, in numerous indications, including sports concussions.

CogState will acquire the 50% stake for 7,461,831 CogState Ltd fully paid ordinary shares at a notional price of $0.17 per share.

News

Insider Trades

Global

COGZF

Cogstate Acquires 100% Holding of Axon Sports

Cogstate Ltd (AU:CGS) has released an update. Bradley O'Connor, a director at Cogstate Ltd, has notably altered his holdings in the company by exer...

Cogstate Director's Stake Changes Post Transactions

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd, a company specializing in neuroscience technology for brain health assessments, has ann...

Cogstate Ltd Announces Hybrid FY2024 AGM

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced the cessation of 65,033 performance rights due to unmet conditions, effect...

Cogstate Ltd Reports Performance Rights Cessation

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced the application for quotation of a total of 1,816,078 new fully paid ordin...

Cogstate Ltd Announces New ASX Securities

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced the cessation of over 1.2 million options due to failure to meet condition...

Cogstate Ltd Options Cease as Conditions Unmet

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced the issuance of 3,756,569 new performance rights as part of their employee...

Cogstate Ltd Issues New Employee Incentive Securities

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced the cessation of 31,914 performance rights due to unmet conditions as of O...

Cogstate Ltd Reports Lapse of Performance Rights

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced a new on-market share buyback program, allowing the repurchase of up to 10...

Cogstate Ltd Launches New Share Buyback Program

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd, a leader in neuroscience technology, continues to enhance brain health assessments thro...

Cogstate Ltd Expands Brain Health Assessment Innovations

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd has announced a partnership with Medidata to deliver a unified solution for central nerv...

Comments

Cogstate

Notizie

Ultime notizie per Cogstate (OTC:COGZF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO